New Pancreatic Cancer Drug Doubles Survival Time in Trial

A breakthrough pill for pancreatic cancer almost doubled survival time and cut death risk by 60% in a major trial.

Revolution Medicines plans to seek fast-track FDA approval for patients who desperately need new treatment options.